John P. Schmid - 13 Jan 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
13 Jan 2025
Net transactions value
+$275,007
Form type
4
Filing time
15 Jan 2025, 17:04:11 UTC
Previous filing
08 Jan 2025
Next filing
27 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Options Exercise $98,699 +21,692 +556% $4.55 25,592 13 Jan 2025 Direct F1
transaction ANAB Common Stock Options Exercise $176,308 +20,645 +81% $8.54 46,237 13 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Stock Option (right to buy) Options Exercise $0 -21,692 -100% $0.000000 0 13 Jan 2025 Common Stock 21,692 $4.55 Direct F2
transaction ANAB Stock Option (right to buy) Options Exercise $0 -20,645 -100% $0.000000 0 13 Jan 2025 Common Stock 20,645 $8.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercises reported on this Form 4 for various stock options are expiring in 2025 and the Reporting Person wished to facilitate the exercises of such options before their expiration. The Reporting Person does not intend to currently sell any of the said exercised shares in this Form 4.
F2 The option is fully vested.